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Objectives The purpose of this study was to determine hospitalizations for heart failure in the U.S. during the past 26 years.
Background Heart failure increased in the U.S.; however, little is known about the long-term trends in diseases leading to
hospitalizations among patients with heart failure.
Methods Using National Hospital Discharge Survey data from 1979 to 2004, we assessed trends in hospitalizations for
heart failure as either a first-listed or additional (2nd to 7th) diagnosis. Among hospitalizations with any mention
of heart failure, we assessed the distribution of first-listed diagnoses.
Results The number of hospitalizations with any mention of heart failure tripled from 1,274,000 in 1979 to 3,860,000
in 2004; 65% to 70% of admissions were patients with additional diagnoses of heart failure. Heart failure hospi-
talization rates increased sharply with age. More than 80% of hospitalizations were among patients of at least
65 years and were paid by Medicare/Medicaid. Age-adjusted hospitalization rates between 1979 and 2004 in-
creased for heart failure as either the first-listed or additional diagnosis. Whereas heart failure was the first-
listed diagnosis for 30% to 35% of these hospitalizations, the proportion with respiratory diseases and noncar-
diovascular, nonrespiratory diseases as the first-listed diagnoses increased. Heart failure hospitalizations that
resulted in transfers to long-term care facilities increased, and in-hospital mortality and length of hospital stay
declined.
Conclusions With the increased aging of the U.S. population and advanced therapeutic interventions that improve survival, it
is expected that heart failure hospitalizations at older ages and the associated economic burden to Medicare
will continue to increase in the future. (J Am Coll Cardiol 2008;52:428–34) © 2008 by the American College
of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.061d
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ceart failure morbidity among older adults began increasing
n the mid-1980s (1–4), with advances in treatment for
oronary heart disease (CHD), stroke and hypertension,
nd improved survival for persons with these conditions.
eart failure has become a major public health concern,
specially for elderly Americans (5,6), and has been
escribed as a “new” or “emerging” epidemic for the 21st
entury (7,8). Among all adults age 40 years, 1 in 5 will
evelop heart failure at some point in their lifetimes (9).
urrently 5.2 million Americans (2.5%) are estimated
o have heart failure (10). In 2007 the estimated direct
nd indirect costs of heart failure in the U.S. was $33.2
illion (10).
rom the *Division for Heart Disease and Stroke Prevention, †Office of the Director,
nd the ‡Division of Adult and Community Health, National Center for Chronic
isease Prevention and Health Promotion, Centers for Disease Control and
revention, Atlanta, Georgia. The findings and conclusions in this article are those of
he authors and do not represent the views of the Centers for Disease Control and
revention.C
Manuscript received November 9, 2007; revised manuscript received March 5,
008, accepted March 18, 2008.The rate of heart failure hospitalizations, particularly in
eveloped countries with aging populations, has increased
rogressively over the past decades (1–4,11–15), making it
he most common condition for hospital admission in
lderly patients, followed by pneumonia, cerebrovascular
isease, cancer, and coronary atherosclerosis (16). To update
hese trends into the 21st century, we analyzed the National
ospital Discharge Survey (NHDS) data from 1979 to
004 to examine annual hospitalization rates and trends in
haracteristics for patients hospitalized with heart failure as
ither the first-listed diagnosis or additional (2nd to 7th)
iagnosis. We also assessed the trends in other clinical
onditions that lead to hospitalization among patients with
ny mention of heart failure.
See page 435
ethods
ata. We used the NHDS data, 1979 to 2004, which was
onducted by the National Center for Health Statistics,
enters for Disease Control and Prevention. The NHDS
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August 5, 2008:428–34 Heart Failure Hospitalizationollected annual data from a sample of in-patient records
cquired from a national sample of hospitals (16). General
r children’s general hospitals and hospitals with an average
ength of stay of fewer than 30 days for all patients were
ncluded in the survey. Federal, military, and Veterans
ffairs hospitals, as well as hospital units of institutions and
ospitals with fewer than 6 beds staffed for patient use, were
xcluded. Prior to 1988, the NHDS was based on a 2-stage
esign. The survey was redesigned in 1988 (17). The new
ample design used a modified, 3-stage design. Although
here are a number of less significant differences between the
riginal and new designs that have been documented, the
hanges do not affect the ability to conduct trend analysis (17).
The discharge records were selected within sampled
ospitals using systematic random sampling. Because dis-
harges were sampled, an individual patient might appear
ore than once in the sample if he/she had more than 1
ospitalization within the survey period. The medical record
ace sheet and discharge summary were primarily used to
xtract patient information onto the survey form. Variables
ollected in the NHDS conformed with the Uniform
ospital Discharge Data Set (18,19). These variables in-
luded birth date or age, gender, race, marital status,
dmission and discharge dates, discharge status, expected
ource(s) of payment, and information on diagnoses and
rocedures.
Heart failure was defined with American College of
ardiology/American Heart Association heart failure per-
ormance measures International Classification of Diseases-
inth Revision-Clinical Modification (ICD-9-CM) diagnosis
odes (Table 1) (20) for first-listed diagnoses (principal diag-
oses) or additional diagnoses (2nd to 7th listed diagnoses).
mong hospitalizations with additional diagnoses of heart
ailure, the first-listed diagnoses were identified. These in-
luded CHD (ICD-9-CM 410 to 414); other diseases of
he heart (ICD-9-CM 391 to 392, 393 to 398, 402, 404,
15 to 416, 420 to 427, and 429); other cardiovascular
iseases (CVDs) (ICD-9-CM 390 to 459, exclusive of the
revious codes for CHD and other diseases of the heart);
espiratory diseases (ICD-9-CM 460 to 519), including
neumonia and chronic obstructive pulmonary disease; and
ll other non-CVD and nonrespiratory conditions. We also
dentified comorbidities of hypertension (ICD-9-CM 401
o 405) and diabetes (ICD-9-CM 250) by 2nd through 7th
iagnoses.
tatistical analysis. Hospitalization rates were calculated for
979 through 2004 using the estimated number of hospital-
zations as the numerator and the U.S. civilian population (16)
s the denominator. Annual age-standardized hospitalization
ates (per 100,000) were calculated using the 2000 U.S.
tandard population. Age-specific rates and trends in charac-
eristics were assessed for the following 5-year aggregated time
eriods: 1980 to 1984, 1985 to 1989, 1990 to 1994, 1995 to
999, and 2000 to 2004. Relative percent changes (RPC) were
stimated by the changes over the 2 periods divided by the first
f the period. All analyses were conducted with SPSS, ac-
A
tounting for total weight to obtain
stimates of U.S. hospitalization.
esults
uring the 26-year period, the
stimated number of hospitaliza-
ions for heart failure as any of
he 7 diagnoses was 1,274,000 in
979 and tripled to 3,860,000 by
004. The estimated number for
eart failure as the first-listed
iagnosis increased from 409,000
n 1979 to 1,166,000 in 2004. Of
ll heart failure hospitalizations,
here were 69% whites, 11%
lacks, 1% Asians/Pacific Island-
rs, 1% others, and 18% with race missing or unknown.
urther analysis by race was not conducted because of a
elatively high number of missing reports (21).
ospitalization rates. Age-adjusted hospitalization rates
per 100,000) increased from 219 in 1979 to 390 in 2004
RPC 79%; 95% confidence interval [CI]: 67% to 93%)
CC/AHA Heart Failureerformance Measures ICD-9-CM Diagnosis Codes
Table 1 ACC/AHA Heart FailurePerformance Measures ICD-9-CM Diagnosis Codes
ICD-9-CM
Code Description
402.01 Malignant, hypertensive heart disease with heart failure
402.11 Benign, hypertensive heart disease with heart failure
402.91 Unspecified, hypertensive heart disease with heart failure
404.01 Malignant, hypertensive heart and renal disease with
heart failure
404.03 Malignant, hypertensive heart and renal disease with
heart failure and renal failure
404.11 Benign, hypertensive heart and renal disease with
heart failure
404.13 Benign, hypertensive heart and renal disease with
heart failure and renal failure
404.91 Unspecified, hypertensive heart and renal disease with
heart failure
404.93 Unspecified, hypertensive heart and renal disease with
heart failure and renal failure
428.00 Unspecified, congestive heart failure
428.01 Left heart failure
428.09 Unspecified, heart failure
428.20 Unspecified, systolic heart failure
428.21 Acute systolic heart failure
428.22 Chronic systolic heart failure
428.23 Acute or chronic systolic heart failure
428.30 Unspecified, diastolic heart failure
428.31 Acute diastolic heart failure
428.32 Chronic diastolic heart failure
428.33 Acute or chronic diastolic heart failure
428.40 Unspecified, combined systolic and diastolic heart failure
428.41 Acute combined systolic and diastolic heart failure
428.42 Chronic combined systolic and diastolic heart failure
428.43 Acute or chronic combined systolic and diastolic heart failure
Abbreviations
and Acronyms
CHD  coronary heart
disease
CI  confidence interval
CVD  cardiovascular
disease
ICD-9-CM  International
Classification of Diseases-
Ninth Revision-Clinical
Modification
NHDS  National Hospital
Discharge Survey
RPC  relative percentage
changeCC/AHA  American College of Cardiology/American H
ional Classification of Diseases-Ninth Revision-Clinical Moeart Association; ICD-9-CM  Interna-
dification.
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Heart Failure Hospitalization August 5, 2008:428–34or the first-listed diagnosis of heart failure and more than
oubled from 461 in 1979 to 937 in 2004 (RPC 103%;
5% CI: 92% to 116%) for heart failure as an additional
iagnosis. For both first-listed and additional diagnoses of
eart failure, the age-adjusted hospitalization rates were
igher in men than in women (Fig. 1).
To determine age and gender impact on heart failure
ospitalization, we measured annual age-specific (65, 65
o 74, and 75 years) heart failure hospitalization rates by
ender for both first-listed diagnosis and additional diag-
osis. From 1979 to 2004, in all age and gender groups,
here were steady increases in heart failure hospitalization
ates. Table 2 summarizes the hospitalization rates and
PC from 1979 to 2004. Although those younger than 65
ears had the lowest hospitalization rates, they had the
ighest relative increases over the period. Men had higher
ospitalization rates than women in all age groups. Among
atients age 65 years and older, the RPCs were similar
etween men and women among first-listed heart failure
ospitalization. However, among hospitalization with heart
ailure as an additional diagnosis, women had a higher
ncrease over the period.
ther characteristics. We compared patient characteristics
cross 5-year aggregated time periods for hospitalizations with
ny mention of heart failure (Table 3). During these time
eriods, more than one-half of the patients were women. More
han 80% of hospitalizations for heart failure occurred among
he Medicare-aged population (65 years), except during the
ost recent 2000 to 2004 time period (78%). In fact, more
han 80% of these hospitalizations were covered by Medicare
nd/or Medicaid. The age distribution of patients hospitalized
or heart failure has changed during the past 2 decades so that
he proportion of patients older than 85 years increased from
7.9% in 1980 to 1984 to 23.7% by 2000 to 2004, and the
roportion of patients age 65 to 74 years decreased from 27.9%
Figure 1 Age-Adjusted Hospitalization Rates for Heart Failure.
Trends of age-adjusted heart failure hospitalization rate (per 100,000) from 1979
among patients with heart failure as the first-listed or additional (2nd to 7th) diagno 21.5%. Patients with secondary diagnoses of hypertension
nd diabetes increased over the years. There were increases in
he proportion of hospitalizations resulting in transfers to
hort- and long-term care facilities, but a decrease in the
roportion discharged home. The median hospital stay and the
roportion of in-hospital deaths declined during this time period.
Among hospitalizations with any listed diagnosis of heart
ailure, approximately 30% had a first-listed diagnosis of
eart failure, regardless of time period. The majority of
ospitalizations were primarily due to diseases other than
eart failure. Distributions of first-listed diagnoses in Table
nal Hospital Discharge Survey, 1979–2004
4
or men and women.
ospitalization Rates (per 100,000) for Heartailure as the Firs -Listed Diagnosis or as Additional2nd o 7th) Diagno is by Age and Gender, 1979nd 2004: Nat onal Hospital Discharge Survey
Table 2
Hospitalization Rates (per 100,000) for Heart
Failure as the First-Listed Diagnosis or as Additional
(2nd to 7th) Diagnosis by Age and Gender, 1979
and 2004: National Hospital Discharge Survey
1979 2004 RPC 95% CI
Heart failure as first diagnosis
Men
65 yrs 50.9 134.0 163.2 118.2–225.3
65–74 yrs 865.6 1,469.7 69.8 64.2–75.9
75 yrs 2,288.8 3,788.9 65.5 62.2–69.0
Women
65 yrs 39.3 98.2 149.7 103.4–216.6
65–74 yrs 667.9 1,116.1 67.1 61.0–73.9
75 yrs 1,976.7 3,402.4 72.1 68.2–76.2
Heart failure as additional diagnosis
Men
65 yrs 108.4 222.9 105.5 83.9–132.8
65–74 yrs 1,771.1 3,213.1 81.4 76.8–86.3
75 yrs 4,757.7 9,169.2 92.7 89.5–96.0
Women
65 yrs 94.5 225.3 138.5 108.9–176.1
65–74 yrs 1,394.9 2,835.8 103.3 96.9–110.1
75 yrs 4,101.8 8,532.6 108.0 104.1–112.1
I  confidence interval; RPC  relative percentage change.Natio
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August 5, 2008:428–34 Heart Failure Hospitalizationindicate that there was a decline in the proportion of
HD and other CVD as the first-listed diagnosis, as well as
n increase in proportion of respiratory and other non-
VD, nonrespiratory diseases from 1980 to 1984 to 2000 to
004. In fact, over the 26-year period, the RPC for
rst-listed conditions were: CHD, 50% (95% CI: 24%
o 106%); other CVD, 39% (95% CI: 11% to
120%), and heart failure, 6% (95% CI: 4% to 10%).
f note is the increased proportion for first-listed diagnoses
f respiratory diseases (including pneumonia) (RPC 52%;
5% CI: 24% to 88%) and other non-CVD, nonrespiratory
iseases (RPC 48%; 95% CI: 28% to 80%).
For 1980 to 1984 and the more recent 2000 to 2004 time
eriods, we compared patient characteristics between hos-
italizations having first-listed diagnoses of heart failure
ith those having additional (2nd to 7th) diagnoses of heart
ailure (Table 4). Regardless of time period, there were
reater proportions of patients older than 85 years, more
ransfers to long-term care facilities, and more in-hospital
Selected Characteristics of Hospitalizations forDiagnoses, by 5-Year Time Periods: N al Ho
Table 3 Selected Characteristics of HospitaDiagnoses, by 5-Year Time Periods:
Characteristic 1980–1984 1
Number of hospitalizations 7,707,000
Age, mean  SD 73.3 13.5 7
Age group, %
44 yrs 2.7
45–64 yrs 16.9
65–74 yrs 28.0
75–84 yrs 34.7
85 yrs 17.8
Women, % 56.8
Source of payment, %
Self-pay 0.2
Medicare/Medicaid 87.8
Private, including HMO 11.9
Others 0.1
Comorbidity, %
Hypertension 15.4
Diabetes 17.4
Median no. of hospital days 8
Discharge status, %
Home 70.6
Other short-term facilities 4.1
Long-term facilities* 8.2
Against medical advice 0.4
Death 10.9
Unknown 5.8
First-listed diagnosis, %
Heart failure 31.7
Coronary heart disease 19.8
Other heart disease 8.4
Other CVD 6.1
Respiratory disease 11.3
Non-CVD, nonrespiratory disease 22.7
*Long-term care facility includes nursing home, skilled nursing facility, e
CVD  cardiovascular disease; HMO  health maintenance organizeaths among those with additional diagnoses of heart failure compared with those with heart failure as first-listed
iagnosis. Over the 26 years, there were consistent declines
n in-hospital mortality (RPC 44%; 95% CI: 18% to
117%), and the decline was larger among those with heart
ailure as the first-listed diagnosis (RPC 60%; 95% CI:
18% to 199%) than those with heart failure as the
dditional listed diagnosis (RPC 38%; 95% CI: 15%
o 95%).
iscussion
eart failure-related hospitalizations increased between
979 and 2004. This increase was consistent with other
arlier reports of national hospitalization data (1–4,11–13);
owever, our report provides the most recent data. This
ncrease was greater for hospitalizations among patients
ith heart failure as an additional diagnosis than among
hose with heart failure as the first-listed diagnosis. More-
ver, among hospitalizations with any mention of heart
t Failure as Any of 7 Listedl Discharge Survey, 1980–2004
ons for Heart Failure as Any of 7 Listed
onal Hospital Discharge Survey, 1980–2004
989 1990–1994 1995–1999 2000–2004
000 12,424,000 16,103,000 18,288,000
13.5 73.9 13.9 74.4 13.6 74.1 14.0
3.2 3.1 3.1
15.8 16.0 18.5
25.8 23.7 21.7
33.9 34.6 33.1
21.3 22.6 23.6
55.9 57.2 56.9
1.2 1.4 1.5
83.8 82.8 83.2
12.5 14.6 13.4
2.5 1.2 1.9
25.4 32.8 40.5
25.2 27.1 27.4
7 5 5
62.8 59.7 57.3
4.9 6.1 6.9
14.4 17.7 19.1
0.5 0.5 0.5
9.6 7.5 6.5
7.8 8.5 9.7
32.8 31.6 30.3
14.2 12.4 10.9
6.7 6.7 6.1
4.7 4.7 4.4
15.7 17.4 18.2
25.9 27.2 30.1
d care facility, intermediate care facility, and/or custodial care facility.
r other managed care plan.Hearspita
lizati
Nati
985–1
9,061,
3.7
3.0
16.5
27.0
34.1
19.5
55.8
0.9
86.8
11.6
0.7
19.2
21.7
7
67.5
3.6
13.2
0.5
10.9
4.3
33.9
16.9
7.6
4.8
13.6
23.2ailure, the proportion with a first-listed diagnosis of CHD
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Heart Failure Hospitalization August 5, 2008:428–34nd other CVD declined. However, the proportions of
ospitalizations with first-listed diagnoses of respiratory or
ther non-CVD increased and surpassed CHD as the most
ommon first-listed diagnosis. During the same period,
n-hospital mortality declined among patients hospitalized
ith heart failure. This decline was greater among hospi-
alizations with heart failure as the first-listed diagnosis than
mong those with an additional diagnosis of heart failure.
The growing burden of heart failure can probably be
xplained by multiple converging factors, including the
ging of the U.S. population and the widespread availability
f revascularization procedures leading to improved survival
f patients following acute myocardial infarction (22–25).
owever, many of these survivors develop heart failure later
n life (26). Therefore, despite an overall decline in age-
djusted mortality from CHD in the U.S. (10), heart failure
ncidence and hospitalization rates have increased (1–
,7,8,10–13,27). As mortality from myocardial infarction
nd other CHD continues declining and aging of the U.S.
opulation continues, it is likely that increases in the
ncidence and prevalence of heart failure in the U.S. will also
ontinue. Further improvement in medical therapy for heart
ailure is likely to result in declining mortality and case
atality but increasing morbidity and economic costs.
Although overall heart failure-related hospitalizations
ncreased, the increase was greater among hospitalizations
Characteristics of Hospitalizations for Heart Faias Additional (2nd t 7th) Diagnosis: National H1980–1984 and 2000–2004
Table 4
Characteristics of Hospitalizations
as Additional (2nd to 7th) Diagnosi
1980–1984 and 2000–2004
Characteristic
1980–1
First Listed
Number 2,441,000
Age group, %
44 yrs 2.5
45–64 yrs 17.4
65–74 yrs 28.3
75–84 yrs 34.7
85 yrs 17.1
Age, mean  SD 73.2 13.2
Women, % 56.6
Source of payment, %
Self-pay 0.2
Medicare/Medicaid 88.1
Private, including HMO 11.6
Others 0.1
Median hospital days 7
Discharge status, %
Home 74.0
Other short-term facilities 3.4
Long-term facilities* 6.8
Against medical advice 0.5
Death 9.2
Unknown 6.1
*Long-term care facility includes nursing home, skilled nursing facility, ex
HMO  health maintenance organization or other managed care plhat included heart failure listed as an additional diagnosis. hnterestingly, among hospitalizations with any diagnosis of
eart failure, the percentages of hospitalizations with CHD,
ther heart disease, and other CVD as the first diagnosis
lso declined. By contrast, the proportion of hospitalizations
ith non-CVD as the first-listed diagnosis increased over
he period, suggesting that noncardiac chronic conditions
re becoming more common in heart failure-related hospi-
alizations. These noncardiac conditions, such as respiratory
iseases, were more prevalent in hospitalizations of older
atients with heart failure and are strongly associated with
dverse clinical outcomes leading to patient hospitalization
28). According to Braunstein et al. (28), the most common
oncardiac conditions that led to heart failure-related hos-
italization are chronic obstructive pulmonary disease,
ronchiectasis, lower respiratory disease, asthma, and acute
nd chronic renal failure.
The increased reporting of non-CVD conditions as the
rst-listed diagnosis among hospitalizations of heart failure
atients may be explained by underutilization of effective
eart failure therapies in the presence of other conditions
hat contraindicate the use of these therapies. For example,
sing beta-blockers in asthma or angiotensin-converting
nzyme inhibitors in renal insufficiency could have a nega-
ive impact on these conditions and lead to hospitalization
29,30). By contrast, with advanced prevention and treat-
ent for CVD over the past decades, it is possible to control
s the First-Listed Diagnosis oral Discharge Survey,
art Failure as the First-Listed Diagnosis or
tional Hospital Discharge Survey,
2000–2004
condary First Listed Secondary
266,000 5,575,000 12,713,000
2.7 3.7 2.8
16.6 21.7 17.2
27.9 22.1 21.5
34.7 31.7 33.8
18.1 20.9 24.8
.3 13.7 72.8 14.2 74.7 13.9
56.8 55.3 57.6
0.2 2.2 1.3
87.7 81.3 84.0
12.0 14.6 12.9
0.1 1.9 1.8
9 4 5
69.0 67.7 52.8
4.4 5.6 7.5
8.9 13.4 21.6
0.3 0.7 0.5
11.7 3.9 7.6
5.7 8.7 10.1
care facility, intermediate care facility, or custodial care facility.lure aospit
for He
s: Na
984
Se
5,
73eart failure adequately and minimize heart failure hospi-
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August 5, 2008:428–34 Heart Failure Hospitalizationalizations caused by other CVD. Additionally, patients
ith heart failure are more likely to experience illness from
nfluenza and pneumonia, which can lead to hospitalizations
29,31). The opportunity to reduce hospitalizations among
eart failure patients includes managing and treating pa-
ients with noncardiac diseases appropriately rather than
ontrolling for cardiac disease alone.
Other possible explanations for increasing additional
iagnoses of heart failure are the “upcoding” of heart failure
ischarge diagnosis for quality assurance. Patients with
eart failure pose a challenge for hospital care (32,33). The
mpact of heart failure as a comorbidity includes more
edications and higher risk of adverse interactions, more
requent doctor visits and higher health care costs, impaired
uality of life, and higher mortality (34). Furthermore, the
.S. Centers for Medicare and Medicaid Services reim-
urses hospitals for Medicare patients on the basis of
iagnosis-related groups. For other primary diagnoses, the
resence of complications increased the level of reimburse-
ent (35). Because heart failure qualifies as a complication,
here was economic incentive for coding heart failure as a
omplication (36).
Between 1979 and 2004, in-hospital deaths among heart
ailure hospitalizations declined substantially. During this
ime, increased use of angiotensin-converting enzyme in-
ibitors, beta-blockers, diuretics, and digoxin; declines in
he use of potentially harmful drug therapies (e.g., calcium
hannel blockers); and increased use of beneficial invasive
rocedures (e.g., revascularization procedures) all may have
ad an impact on in-hospital mortality (37–40). Although
esults here indicate that in-hospital mortality declined
uring the past 2 decades, it is possible that mortality among
eart failure patients has merely shifted to another setting,
uch as chronic rehabilitation hospitals or skilled nursing
acilities. In fact, our data showed that discharges to
ong-term care facilities increased during the period. Un-
ortunately, NHDS does not include information on post-
ischarge mortality.
The strengths of NHDS include its large size, repre-
entative quality, standardized methodology, and ability
o examine long-term trends in hospitalizations (16).
owever, major limitations of this administrative data-
ase include the inability to validate diagnoses or proce-
ure use, assess racial or state variations, or determine
ostdischarge mortality. In addition, the data provides
inimal clinical detail to assess disease severity. Further-
ore, the analyses are based on hospital admissions
ather than the patients. Finally, without access to
ampling design weight, we were unable to estimate
tandard errors. However, these limitations should not
ffect the internal accuracy of this study.
onclusions
n summary, during the past 26 years, U.S. hospitalizations
or heart failure increased, particularly among patients with
1eart failure as an additional diagnosis. With aging of the
.S. population, advanced therapeutic interventions and
mproved survival for patients with acute myocardial infarc-
ion and other CHD, it is expected that heart failure
ospitalizations could continue increasing in the future.
his will substantially increase health care costs paid by
edicare/Medicaid. To reduce heart failure hospitaliza-
ions, therapeutic strategies should include preventive treat-
ent for noncardiac conditions to decrease the number of
ospitalizations.
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